Stefano Severi

2.4k total citations
59 papers, 1.6k citations indexed

About

Stefano Severi is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Stefano Severi has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 32 papers in Epidemiology and 26 papers in Neurology. Recurrent topics in Stefano Severi's work include Neuroendocrine Tumor Research Advances (32 papers), Lung Cancer Research Studies (29 papers) and Neuroblastoma Research and Treatments (25 papers). Stefano Severi is often cited by papers focused on Neuroendocrine Tumor Research Advances (32 papers), Lung Cancer Research Studies (29 papers) and Neuroblastoma Research and Treatments (25 papers). Stefano Severi collaborates with scholars based in Italy, United States and Germany. Stefano Severi's co-authors include Giovanni Paganelli, Lisa Bodei, Maddalena Sansovini, Silvia Nicolini, Manuela Monti, Annarita Ianniello, Emanuela Scarpi, Alberto Bongiovanni, Federica Matteucci and Mark Kidd and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Stefano Severi

58 papers receiving 1.5k citations

Peers

Countries citing papers authored by Stefano Severi

Since Specialization

Citations

This map shows the geographic impact of Stefano Severi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Severi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Severi more than expected).

Fields of papers citing papers by Stefano Severi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Severi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Severi. The network helps show where Stefano Severi may publish in the future.

Co-authorship network of co-authors of Stefano Severi

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Severi. A scholar is included among the top collaborators of Stefano Severi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Severi. Stefano Severi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial 2021 ·British Journal of Cancer ·Ugo De Giorgi, Maddalena Sansovini, Stefano Severi, Silvia Nicolini, Manuela Monti, Giorgia Gurioli, Flavia Foca, Chiara Casadei, Vincenza Conteduca, Monica Celli, Valentina Di Iorio, Daniele Calistri, Federica Matteucci, Finn Edler von Eyben, Gerhardt Attard, Giovanni Paganelli	20
2	Theragnostic in neuroendocrine tumors 2021 ·The Quarterly Journal of Nuclear Medicine and Molecular Imaging ·Irene Marini, Maddalena Sansovini, Alberto Bongiovanni, Silvia Nicolini, Ilaria Grassi, (unknown), Manuela Monti, Valentina Di Iorio, (unknown), Paola Caroli, Anna Sarnelli, Giovanni Paganelli, Stefano Severi	4
3	177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Giovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, Ilaria Grassi, Toni Ibrahim, (unknown), Valentina Di Iorio, Manuela Monti, Emanuela Scarpi, Alberto Bongiovanni, Mattia Altini, Luca Urso, Corrado Cittanti, Federica Matteucci, Stefano Severi	24
4	Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen) 2020 ·Frontiers in Oncology ·Maria Luisa Belli, Anna Sarnelli, Emilio Mezzenga, (unknown), Paola Caroli, Valentina Di Iorio, Lidia Strigari, Marta Cremonesi, Antonino Romeo, Silvia Nicolini, Federica Matteucci, Stefano Severi, Giovanni Paganelli	26
5	1175P Temozolomide alone or combined with capecitabine for the treatment of metastatic neuroendocrine neoplasia: A “Real World” data analysis 2020 ·Annals of Oncology ·Alberto Bongiovanni, Chiara Liverani, Flavia Foca, (unknown), Federica Pieri, (unknown), Riccardo Galassi, Davide Cavaliere, Stefano Severi, Valentina Fausti, Giandomenico Di Menna, Laura Mercatali, Alessandro De Vita, Nada Riva, Sebastiano Calpona, Giacomo Miserocchi, Chiara Spadazzi, Toni Ibrahim	1
6	Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis 2020 ·Frontiers in Oncology ·Alberto Bongiovanni, Chiara Liverani, Federica Recine, Valentina Fausti, Laura Mercatali, (unknown), Chiara Spadazzi, Giacomo Miserocchi, Claudia Cocchi, Giandomenico Di Menna, Alessandro De Vita, Stefano Severi, Silvia Nicolini, Toni Ibrahim	10
7	Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Giovanni Paganelli, Anna Sarnelli, Stefano Severi, Maddalena Sansovini, Maria Luisa Belli, Manuela Monti, Flavia Foca, Monica Celli, Silvia Nicolini, Elisa Tardelli, Irene Marini, Federica Matteucci, Melchiore Giganti, Valentina Di Iorio, Ugo De Giorgi	45
8	A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods 2020 ·Journal of Visualized Experiments ·Maria Luisa Belli, Emilio Mezzenga, Valentina Di Iorio, Monica Celli, Paola Caroli, (unknown), Federica Matteucci, Elisa Tardelli, Ilaria Grassi, Maddalena Sansovini, Silvia Nicolini, Stefano Severi, Marta Cremonesi, Mahila Ferrari, Giovanni Paganelli, Anna Sarnelli	8
9	Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol 2019 ·Molecules ·Anna Sarnelli, Maria Luisa Belli, Valentina Di Iorio, Emilio Mezzenga, Monica Celli, Stefano Severi, Elisa Tardelli, Silvia Nicolini, Devil Oboldi, Licia Uccelli, Corrado Cittanti, Manuela Monti, Mahila Ferrari, Giovanni Paganelli	35
10	Ten-year experience of the multidisciplinary Osteoncology Center 2019 ·Supportive Care in Cancer ·Alberto Bongiovanni, Federica Recine, Valentina Fausti, Flavia Foca, Roberto Casadei, (unknown), Devil Oboldi, Elisabetta Sansoni, Laura Fabbri, (unknown), Stefano Severi, Federica Matteucci, (unknown), Laura Mercatali, Dino Amadori, Toni Ibrahim	15
11	Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases 2019 ·The Prostate ·Oliver Sartor, Daniel Heinrich, Neil Mariados, M.J. Méndez Vidal, Daniel Keizman, Camilla Thellenberg Karlsson, Avivit Peer, Giuseppe Procopio, Stephen Jay Frank, Kalevi Pulkkanen, Eli Rosenbaum, Stefano Severi, José Trigo, Lucia Trandafir, Volker Jean Wagner, Rui Li, Luke T. Nordquist	16
12	Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Silvia Nicolini, Stefano Severi, Annarita Ianniello, Maddalena Sansovini, A. Ambrosetti, Alberto Bongiovanni, Emanuela Scarpi, (unknown), (unknown), Federica Matteucci, Giovanni Paganelli	64
13	PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Lisa Bodei, Mark Kidd, Aviral Singh, Wouter A. van der Zwan, Stefano Severi, Ignat Drozdov, Jarosław B. Ćwikła, Richard P. Baum, Dik J. Kwekkeboom, Giovanni Paganelli, Eric P. Krenning, Irvin M. Modlin	96
14	Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases 2017 ·Annals of Oncology ·Oliver Sartor, Daniel Heinrich, Neil Mariados, (unknown), Daniel Keizman, Camilla Thellenberg Karlsson, (unknown), Giuseppe Procopio, Stephen Jay Frank, Kalevi Pulkkanen, Eli Rosenbaum, Stefano Severi, J.M. Trigo Perez, (unknown), (unknown), Luke T. Nordquist	21
15	Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life 2017 ·OncoTargets and Therapy ·Stefano Severi, Ilaria Grassi, Silvia Nicolini, Maddalena Sansovini, Alberto Bongiovanni, Giovanni Paganelli	34
16	Radium-223 re-treatment from an international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases 2016 ·Annals of Oncology ·Oliver Sartor, Daniel Heinrich, Neil Mariados, M.J. Méndez Vidal, Daniel Keizman, Camilla Thellenberg Karlsson, (unknown), Giuseppe Procopio, Stephen Jay Frank, Kalevi Pulkkanen, Eli Rosenbaum, Stefano Severi, J.M. Trigo Perez, (unknown), J. Garcia‐Vargas, (unknown), Luke T. Nordquist	1
17	Radium-223 (Ra-223) Re-treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC) 2016 ·Annals of Oncology ·Giuseppe Procopio, Stefano Severi, Elena Verzoni, Maddalena Sansovini, Oliver Sartor, Daniel Heinrich, Neil Mariados, M.J. Méndez Vidal, Daniel Keizman, Camilla Thellenberg‐Karlsson, (unknown), Stephen Jay Frank, Kalevi Pulkkanen, J.M. Pérez, Luke T. Nordquist	1
18	Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Stefano Severi, Maddalena Sansovini, Annarita Ianniello, Lisa Bodei, Silvia Nicolini, Toni Ibrahim, Valentina Di Iorio, (unknown), Paola Caroli, Manuela Monti, Giovanni Paganelli	51
19	Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·Stefano Severi, Oriana Nanni, Lisa Bodei, Maddalena Sansovini, Annarita Ianniello, (unknown), Emanuela Scarpi, Federica Matteucci, Laura Gilardi, Giovanni Paganelli	91
20	A case of metachronous double primary neuroendocrine cancer in pancreas/ileum and uterine cervix 2012 ·Upsala Journal of Medical Sciences ·Giovanni Sisti, Anna Maria Buccoliero, Luca Novelli, Maddalena Sansovini, Stefano Severi, Annalisa Pieralli, Lorenzo Livi, Massimiliano Fambrini	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact